On May 08, 2014, Regeneron Pharmaceuticals Inc (NASDAQ:REGN), announced financial results for the first quarter of 2014 and provided an update on development programs. First quarter 2014 EYLEA® (aflibercept) Injection global net sales increased 54% to $577 million (consisting of $359 million in the U.S. and $218 million in rest of world(1)) versus first quarter 2013. Regeneron Pharmaceuticals Inc (NASDAQ:REGN), net profit margin is 20.20% and weekly performance is 5.73%. On last trading day company shares ended up $295.43. Analysts mean target price for the company is $345.53. Regeneron Pharmaceuticals Inc (NASDAQ:REGN), distance from 50-day simple moving average (SMA50) is -2.67%.
On May 08, 2014, BASF SE (ADR) (OTCMKTS:BASFY), the German chemical giant, and Yara International ASA, a Norwegian agricultural and environmental solutions provider, announced they are planning to build a “world-scale” ammonia plant outside of Houston in Freeport. BASF SE (ADR) (OTCMKTS:BASFY), fell 1.22% in last trading session and ended the day on $112.73.
AstraZeneca plc (ADR) (NYSE:AZN), saw unusually large options trading activity on Friday. Stock traders bought 18,875 put options on the company, American Banking & Market News reports. This is an increase of 143% compared to the average daily volume of 7,762 put options. AstraZeneca plc (ADR) (NYSE:AZN), shares moved down 0.30% in last trading session and was closed at $80.28, while trading in range of $79.65 – 81.19. AstraZeneca plc (ADR) (NYSE:AZN), year to date (YTD) performance is 39.11%.
On May 09, 2014,Syngenta AG (ADR) (NYSE:SYT), said it will start a second African seed-treatment institute in Kenya in 2016 and plans to expand in the continent’s western nations in the next five years. Syngenta AG (ADR) (NYSE:SYT), ended the last trading day at $78.06. Company weekly volatility is calculated as 0.72% and price to cash ratio as 40.62. Syngenta AG (ADR) (NYSE:SYT), showed a positive weekly performance of 0.22%.
E I Du Pont De Nemours And Co (NYSE:DD), EVP Thomas Connelly, Jr. sold 16,552 shares of E I Du Pont De Nemours And stock in a transaction that occurred on Wednesday, May 7th. The shares were sold at an average price of $67.50, for a total value of $1,117,260.00. Following the completion of the sale, the executive vice president now directly owns 175,053 shares of the company’s stock, valued at approximately $11,816,078. E I Du Pont De Nemours And Co (NYSE:DD), net profit margin is 8.20% and weekly performance is -0.46%. On last trading day company shares ended up $67.02. Analysts mean target price for the company is $69.43. E I Du Pont De Nemours And Co (NYSE:DD), distance from 50-day simple moving average (SMA50) is 0.60%.